HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nobuaki Miyahara Selected Research

Respiratory Hypersensitivity

1/2019Requirement for neuropeptide Y in the development of type 2 responses and allergen-induced airway hyperresponsiveness and inflammation.
6/2016Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation.
10/2015Contrasting roles for the receptor for advanced glycation end-products on structural cells in allergic airway inflammation vs. airway hyperresponsiveness.
1/2014Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
1/2013Inhibition of neutrophil elastase attenuates airway hyperresponsiveness and inflammation in a mouse model of secondary allergen challenge: neutrophil elastase inhibition attenuates allergic airway responses.
12/2011Requirement for chemokine receptor 5 in the development of allergen-induced airway hyperresponsiveness and inflammation.
7/2010Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-gamma production.
9/2009Differential effects of dendritic cell transfer on airway hyperresponsiveness and inflammation.
7/2009Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation.
6/2009Leukotriene B4 release from mast cells in IgE-mediated airway hyperresponsiveness and inflammation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nobuaki Miyahara Research Topics

Disease

47Inflammation (Inflammations)
11/2021 - 10/2003
37Respiratory Hypersensitivity
01/2019 - 12/2003
15Eosinophilia
06/2016 - 10/2003
12Asthma (Bronchial Asthma)
02/2022 - 12/2003
12Metaplasia
06/2016 - 01/2006
8Pneumonia (Pneumonitis)
10/2021 - 12/2003
7Emphysema
01/2022 - 01/2013
6Idiopathic Pulmonary Fibrosis
02/2022 - 01/2020
5Interstitial Lung Diseases (Interstitial Lung Disease)
11/2022 - 06/2016
5Chronic Obstructive Pulmonary Disease (COPD)
09/2021 - 06/2016
4Pulmonary Emphysema
01/2022 - 01/2013
4Disease Progression
01/2022 - 01/2013
4Fibrosis (Cirrhosis)
11/2021 - 01/2006
4Allergic Rhinitis
12/2008 - 11/2005
4Infections
01/2008 - 12/2003
4Hyperplasia
05/2006 - 10/2003
3Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2022 - 01/2021
2Neoplasms (Cancer)
02/2022 - 01/2020
2Lung Neoplasms (Lung Cancer)
03/2020 - 01/2020
2Carcinoma (Carcinomatosis)
03/2020 - 01/2017
2Bronchiolitis Obliterans
07/2019 - 12/2011
2Fever (Fevers)
08/2016 - 06/2011
2Reinfection
01/2008 - 08/2005
2Nasal Obstruction
11/2006 - 11/2005
2Respiratory Syncytial Virus Infections
04/2005 - 12/2003
1Respiratory Insufficiency (Respiratory Failure)
11/2022
1Myositis (Idiopathic Inflammatory Myopathies)
11/2022
1Lung Injury
10/2021
1Mikulicz' Disease
09/2021
1Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome)
03/2021
1Organizing Pneumonia
03/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Bronchiolitis Obliterans Syndrome
07/2019
1Hepatomegaly
01/2019
1Hypertriglyceridemia
01/2019
1Pleural Effusion (Pleural Effusions)
01/2019
1Immunoglobulin G4-Related Disease
01/2019

Drug/Important Bio-Agent (IBA)

31AllergensIBA
01/2019 - 10/2003
22CytokinesIBA
11/2021 - 12/2003
19Interleukin-13IBA
09/2009 - 12/2003
11Methacholine Chloride (Methacholine)FDA Link
01/2013 - 12/2003
8Pancreatic Elastase (Elastase)IBA
01/2022 - 01/2013
8OvalbuminIBA
12/2017 - 01/2006
7InterleukinsIBA
05/2021 - 10/2003
7Leukotriene B4IBA
06/2009 - 04/2005
5ChemokinesIBA
04/2015 - 01/2006
5Immunoglobulin E (IgE)IBA
06/2009 - 11/2004
5Interleukin-5 (Interleukin 5)IBA
01/2009 - 02/2004
4Interleukin-17 (Interleukin 17)IBA
11/2021 - 01/2013
4Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA
07/2008 - 07/2005
3Prednisolone (Predate)FDA LinkGeneric
02/2022 - 06/2011
3Immunoglobulin G (IgG)IBA
09/2021 - 01/2006
3Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2006
3Adrenal Cortex Hormones (Corticosteroids)IBA
08/2016 - 04/2008
3LeukotrienesIBA
01/2014 - 06/2006
3Interleukin-4 (Interleukin 4)IBA
09/2007 - 02/2004
3AntigensIBA
06/2006 - 02/2004
2AntibodiesIBA
11/2022 - 11/2004
2Phosphotransferases (Kinase)IBA
02/2022 - 01/2020
2Neuropeptide YIBA
01/2022 - 01/2019
2Bleomycin (Blenoxane)FDA LinkGeneric
11/2021 - 10/2021
2Interleukin-23 (Interleukin 23)IBA
11/2021 - 11/2016
2SmokeIBA
05/2021 - 01/2019
2pirfenidoneIBA
03/2021 - 05/2020
2nintedanibIBA
03/2021 - 01/2020
2Chemotactic FactorsIBA
01/2019 - 07/2005
2Retinoid X Receptors (Retinoid X Receptor)IBA
01/2019 - 01/2017
2Receptor for Advanced Glycation End ProductsIBA
10/2015 - 04/2015
2AerosolsIBA
01/2013 - 10/2011
2Interleukin-10 (Interleukin 10)IBA
05/2007 - 02/2007
2Chemokine CCL5IBA
08/2006 - 01/2006
2aluminum sulfate (alum)IBA
04/2006 - 01/2006
2IgE Receptors (Fc epsilon RI)IBA
11/2005 - 05/2004
1Transfer RNA (tRNA)IBA
11/2022
1asparaginyl-tRNA synthetaseIBA
11/2022
1Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
11/2022
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2022
1LipopolysaccharidesIBA
11/2021
1HydrogenIBA
10/2021
1Oxidants (Oxidizing Agents)IBA
09/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2021
1Biomarkers (Surrogate Marker)IBA
09/2021
1Interleukin-33IBA
05/2021
1Antifibrotic AgentsIBA
03/2021
1indium-bleomycinIBA
01/2021
1Neutralizing AntibodiesIBA
01/2021
1osimertinibIBA
03/2020
1ErbB Receptors (EGF Receptor)IBA
03/2020
1Alkylating AgentsIBA
07/2019
1Bexarotene (LGD1069)FDA Link
01/2019
1InterferonsIBA
01/2019
1Adenosine DeaminaseIBA
01/2019

Therapy/Procedure

8Therapeutics
10/2021 - 11/2006
3Drug Therapy (Chemotherapy)
01/2020 - 12/2011
2Extracorporeal Membrane Oxygenation
11/2022 - 12/2011
2Immunotherapy
08/2016 - 07/2009
2Aftercare (After-Treatment)
08/2016 - 03/2007
2Intranasal Administration
01/2008 - 05/2006
1Radiotherapy
01/2020
1Lung Transplantation
07/2019